119 related articles for article (PubMed ID: 15763450)
1. Short-term effects of montelukast in stable patients with moderate to severe COPD.
Celik P; Sakar A; Havlucu Y; Yuksel H; Turkdogan P; Yorgancioglu A
Respir Med; 2005 Apr; 99(4):444-50. PubMed ID: 15763450
[TBL] [Abstract][Full Text] [Related]
2. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
3. The effect of body mass index on functional parameters and quality of life in COPD patients.
Salepçi B; Eren A; Cağlayan B; Fidan A; Torun E; Kiral N
Tuberk Toraks; 2007; 55(4):342-9. PubMed ID: 18224501
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of montelukast, a leukotriene receptor antagonist, for the treatment of dysmenorrhea: a prospective, double-blind, randomized, placebo-controlled study.
Fujiwara H; Konno R; Netsu S; Odagiri K; Taneichi A; Takamizawa S; Ohwada M; Suzuki M
Eur J Obstet Gynecol Reprod Biol; 2010 Feb; 148(2):195-8. PubMed ID: 19944517
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene receptor antagonists: a good choice in the treatment of premenstrual asthma?
Pasaoglu G; Mungan D; Abadoglu O; Misirligil Z
J Asthma; 2008 Mar; 45(2):95-9. PubMed ID: 18350399
[TBL] [Abstract][Full Text] [Related]
6. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
[TBL] [Abstract][Full Text] [Related]
8. Tiotropium in COPD patients not previously receiving maintenance respiratory medications.
Adams SG; Anzueto A; Briggs DD; Menjoge SS; Kesten S
Respir Med; 2006 Sep; 100(9):1495-503. PubMed ID: 16698259
[TBL] [Abstract][Full Text] [Related]
9. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.
Mucha SM; deTineo M; Naclerio RM; Baroody FM
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):164-72. PubMed ID: 16490874
[TBL] [Abstract][Full Text] [Related]
10. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
11. Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis.
Meltzer EO; Philip G; Weinstein SF; LaForce CF; Malice MP; Dass SB; Santanello NC; Reiss TF
Am J Rhinol; 2005; 19(6):591-8. PubMed ID: 16402647
[TBL] [Abstract][Full Text] [Related]
12. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
Ozgur ES; Atis S; Kanik A
Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
[TBL] [Abstract][Full Text] [Related]
13. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
[TBL] [Abstract][Full Text] [Related]
14. [The efficacy and safety of long term home noninvasive positive pressure ventilation in patients with stable severe chronic obstructive pulmonary disease].
Xiang PC; Zhang X; Yang JN; Zhang EM; Guo WA; Ju LX; Zhang S; Zhu WJ; Lei T; Cheng XS
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):746-50. PubMed ID: 18218204
[TBL] [Abstract][Full Text] [Related]
15. [The evaluation of dyspnea and quality of life in COPD].
Demir G; Akkoca O; Doğan R; Saryal S; Karabiyikoğlu G
Tuberk Toraks; 2003; 51(4):365-72. PubMed ID: 15143383
[TBL] [Abstract][Full Text] [Related]
16. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
Zhou Y; Wang X; Zeng X; Qiu R; Xie J; Liu S; Zheng J; Zhong N; Ran P
Respirology; 2006 Sep; 11(5):603-10. PubMed ID: 16916334
[TBL] [Abstract][Full Text] [Related]
17. Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial.
Veien NK; Busch-Sørensen M; Stausbøl-Grøn B
J Am Acad Dermatol; 2005 Jul; 53(1):147-9. PubMed ID: 15965438
[TBL] [Abstract][Full Text] [Related]
18. Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?
Keskin O; Alyamac E; Tuncer A; Dogan C; Adalioglu G; Sekerel BE
Pediatr Allergy Immunol; 2006 Jun; 17(4):259-68. PubMed ID: 16771779
[TBL] [Abstract][Full Text] [Related]
19. [Quality of life in patients with chronic obstructive pulmonary disease before and after the treatment with prednisone].
Bijata-Bronisz R; Dziedziczko A
Pol Merkur Lekarski; 2004 Sep; 17(99):216-9. PubMed ID: 15628043
[TBL] [Abstract][Full Text] [Related]
20. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]